Dual-Drug Conjugated Glyco-Nanoassemblies for Tumor-Triggered Targeting and Synergistic Cancer Therapy

被引:8
作者
Katmerlikaya, Tugba Gencoglu [1 ]
Dag, Aydan [5 ]
Ozgen, Pinar Sinem Omurtag [2 ,3 ]
Ersen, Busra Cetin [4 ]
机构
[1] Bezmialem Vakif Univ, Inst Hlth Sci, Dept Biotechnol, TR-34093 Istanbul, Turkey
[2] Istanbul Medipol Univ, Sch Pharm, Dept Analyt Chem, TR-34810 Istanbul, Turkey
[3] Marmara Univ, Fac Pharm, Dept Basic Pharm Sci, TR-34854 Istanbul, Turkey
[4] Ankara Haci Bayram Veli Univ, Inst Grad Studies, Dept Chem, TR-06900 Ankara, Turkey
[5] Bezmialem Vakif Univ, Fac Pharm & Pharmaceut Applicat & Res Ctr, Dept Pharmaceut Chem, TR-34093 Istanbul, Turkey
关键词
glyco-nanoassemblies; gemcitabine; cisPt; cellular uptake; synergistic chemotherapy; GEMCITABINE; DELIVERY;
D O I
10.1021/acsabm.2c00749
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Drug-conjugated nanoassemblies potentiate the efficiency of anticancer drugs through the advantages of high drug-loading capacity and passive/active targeting ability in cancer therapy. This study describes the synthesis of gemcitabine (Gem) and cisplatin (cisPt) dual-drug-functionalized glyco-nanoassemblies (GNs) for anticancer drug delivery systems. It also investigates the pH-triggered drug delivery of the conventional anticancer drug cisPt. A Gem-functionalized well-defined glycoblock copolymer backbone (P(iprFruMA-b-MAc)-Gem), which consists of fructose and methacrylic acid segments, was synthesized via a reversible addition-fragmentation chain transfer (RAFT) polymerization method. Following the hydrolysis of the protecting groups on the backbone copolymer, cisPt functionalization of P(FruMA-b-MAc)-Gem in aqueous media was carried out during the transformation of glycoblock polymers into self-assembled spherical glyco-nanoassemblies (GN3). Monodrug-functionalized glyco-nanoassemblies were also prepared either with Gem (GN1) or cisPt (GN2) to compare the synergetic effect of dual-drug conjugated glyco-nanoassemblies (GN3). The sizes of glyco-nanoassemblies GN1, GN2, and GN3 were found as 5.76 +/- 0.64, 59.80 +/- 0.13, and 53.80 +/- 3.90 nm and dispersity (D) values as 0.476, 0.292, and 0.311 by dynamic light scattering (DLS) measurement, respectively. The in vitro studies revealed that the drug-free glyco-nanoassemblies are biocompatible at concentrations higher than 296 mu g/mL. The drug-conjugated glyco-nanoassemblies (GN1 and GN2) exhibited in vitro cytotoxicity against human breast cancer cell lines of MDA-MB-231 comparable to free Gem and cisPt, illustrating an efficient drug release into the tumor environment. Additionally, GNs exhibited higher selectivity and preferential cellular internalization in MDA-MB-231 when compared to healthy cell lines of CCD-1079Sk. These dual-drug conjugated GNs can effectively enhance the killing of cancer cells and increase synergistic chemotherapy.
引用
收藏
页码:5356 / 5364
页数:9
相关论文
共 50 条
  • [31] Redox and pH dual-responsive biodegradable mesoporous silica nanoparticle as a potential drug carrier for synergistic cancer therapy
    He, Yongju
    Shao, Linjie
    Hu, Yao
    Zhao, Fuwen
    Tan, Songwen
    He, Dan
    Pan, Anqiang
    CERAMICS INTERNATIONAL, 2021, 47 (04) : 4572 - 4578
  • [32] Sustained targeting of Bcr-Abl plus leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy
    Acharya, Sarbari
    Sahoo, Sanjeeb K.
    BIOMATERIALS, 2011, 32 (24) : 5643 - 5662
  • [33] Glycosylated AIE-active Red Light-triggered Photocage with Precisely Tumor Targeting Capability for Synergistic Type I Photodynamic Therapy and CPT Chemotherapy
    Zhou, Wei
    Liu, Yi-chen
    Liu, Guang-jian
    Zhang, Yuan
    Feng, Gai-li
    Xing, Guo-wen
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (01)
  • [34] The c(RGDyK)-Conjugated Fe3O4 Nanoparticles with High Drug Load for Dual-Targeting Integrin αvβ3-Expressing Cancer Cells
    Guo, Lin
    Ding, Wence
    Zheng, Li-Min
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (07) : 4858 - 4864
  • [35] Tumor-Targeting, pH-Responsive, and Stable Unimolecular Micelles as Drug Nanocarriers for Targeted Cancer Therapy
    Yang, Xiaoqiang
    Grailer, Jamison J.
    Pilla, Srikanth
    Steeber, Douglas A.
    Gong, Shaoqin
    BIOCONJUGATE CHEMISTRY, 2010, 21 (03) : 496 - 504
  • [36] Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy
    Guo, Fangyuan
    Fu, Qiafan
    Zhou, Kang
    Jin, Chenghao
    Wu, Wenchao
    Ji, Xugang
    Yan, Qinying
    Yang, Qingliang
    Wu, Danjun
    Li, Aiqin
    Yang, Gensheng
    JOURNAL OF NANOBIOTECHNOLOGY, 2020, 18 (01)
  • [37] Double-Layered Metal-Organic-Frameworks-Based Microswimmers for Adaptive Dual-Drug Anti-Cancer Therapy Using Artemisinin-Based Compounds
    Zhong, Yukun
    Li, Haining
    Jiang, Teng
    Mu, Xueliang
    Seki, Munetoshi
    Cheang, U. Kei
    ADVANCED INTELLIGENT SYSTEMS, 2024,
  • [38] Folic Acid-Modified Erythrocyte Membrane Loading Dual Drug for Targeted and Chemo-Photothermal Synergistic Cancer Therapy
    Chen, Zhihao
    Wang, Wanting
    Li, Yusheng
    Wei, Cui
    Zhong, Ping
    He, Dahua
    Liu, Huan
    Wang, Pengfei
    Huang, Zhenpeng
    Zhu, Wanye
    Zhou, Yi
    Qin, Linghao
    MOLECULAR PHARMACEUTICS, 2021, 18 (01) : 386 - 402
  • [39] Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy
    Li, Man
    Shi, Kairong
    Tang, Xian
    Wei, Jiaojie
    Cun, Xingli
    Long, Yang
    Zhang, Zhirong
    He, Qin
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (06) : 1833 - 1843
  • [40] Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles
    Liu, Juan
    Hu, Xixue
    Jin, Shubin
    Liang, Xing-Jie
    Ma, Xiaowei
    JOURNAL OF MATERIALS CHEMISTRY B, 2022, 10 (03) : 384 - 395